High quality Lifitegrast CAS 1025967-78-5 in stock
Lifitegrast CAS:1025967-78-5 is a FDA approved drug for the treatment of keratoconjunctivitis sicca (dry eye syndrome). It is a tetrahydroisoquinoline derivative and lymphocyte function-associated antigen-1 ( LFA-1) antagonist that was discovered through the rational design process. The ophthalmic solution was approved in July, 2016 under the trade name Xiidra. It has shown to protect the corneal surface and alleviate the symptoms of dry eye syndrome with fast onset of action and well tolerated profile in both local and systemic setting.
Lifitegrast CAS:1025967-78-5 (trade name Xiidra) is a drug for the treatment of keratoconjunctivitis sicca (dry eye syndrome). It is applied in the form of eye drops.
Lifitegrast CAS:1025967-78-5 could be supplied in different size with competitive price.
Q1: Can I get some samples?
A: Yes, It is no problem.If you need sample ,please contact with us.
Q2: How to confirm the Product Quality before placing orders?
A:Firstly,we will send the sample for your testing and also provide our testing result.
Secondly,we could accept the third-party inspection.
Q3:What's your MOQ?
A:Normally,our MOQ is 1kg. But it could be according to your actual demandAny quantity is OK.
Q4: How about delivery time?
A:within 3-5 days after payment confirmed. (Chinese holiday not included)
Q5:Is there a discount?
A:Different quantity has different discount.
Q6: How do you treat quality complaint?
A:First of all, our quality control will ensure our quality in advance. If there is a real quality problem caused by us, we will provide good product again or refund your loss.